Menu
Back to User profile » Dr Michelle K White
Papers published by Dr Michelle K White:
Health-Related Quality of Life Instruments for Clinical Trials in AL Amyloidosis: Report from the Amyloidosis Forum HRQOL Working Group
Rizio AA, White MK, D’Souza A, Hsu K, Schmitt P, Quock TP, Signorovitch J, Lousada I, Sanchorawala V
Patient Related Outcome Measures 2023, 14:153-169
Published Date: 18 May 2023
Work Outcomes Among Patients with Light Chain (AL) Amyloidosis: Findings from Three Patient Cohorts
Rizio AA, McCausland KL, White MK, Quock TP
Patient Related Outcome Measures 2021, 12:339-347
Published Date: 15 December 2021
Content Validation of the ATTR Amyloidosis Patient Symptom Survey: Findings from Patient and Clinician Cognitive Debriefing Interviews
Rizio AA, Broderick LE, White MK, Quock TP
Patient Related Outcome Measures 2020, 11:149-160
Published Date: 26 August 2020
Psychometric validation of the Perceived Deficits Questionnaire-Depression (PDQ-D) instrument in US and UK respondents with major depressive disorder
Lam RW, Lamy FX, Danchenko N, Yarlas A, White MK, Rive B, Saragoussi D
Neuropsychiatric Disease and Treatment 2018, 14:2861-2877
Published Date: 29 October 2018
Psychometric validation of the SF-36 Health Survey in light chain amyloidosis: results from community-based and clinic-based samples
White MK, McCausland KL, Sanchorawala V, Guthrie SD, Bayliss MS
Patient Related Outcome Measures 2017, 8:157-167
Published Date: 7 December 2017